About Us

How Can My Company Participate?

Useful Links

These clinical study results are supplied for informational purposes only in the interests of scientific disclosure. They are not intended to substitute for the FDA-approved package insert or other approved labeling.

Drug Details

Company Name Business Partner Drug Name Generic Name Unique ID Studied Indications or Disease Phase Approved Drug Label
Pfizer Inc. Zithromax azithromycin NCT00140023 Pneumonia, Community-Acquired Phase III http://www.pfizer.com/pfizer/download/uspi_zithromax.pdf ; http://www.pfizer.com/pfizer/download/uspi_zithromax600mg.pdf ; http://www.pfizer.com/pfizer/download/uspi_zithromaxIV.pdf
Clinical Study Summary Protocol No. A0661149: A multi-center, open label study to evaluate the efficacy and safety of azithromycin SR in subjects identified as having low risk community-acquired pneumonia (CAP)

Link to ClinicalTrials.gov registration:
http://www.clinicaltrials.gov/ct/show/NCT00140023


Pfizer will use reasonable efforts to include accurate and up-to-date information on the ClinicalStudyResults.org web site. However, because the status of studies often changes, Pfizer can make no, and makes no, warranties or representations of any kind as to the currency or completeness of the information contained therein. You agree that access to and use of information posted by Pfizer on the ClinicalStudyResults.org web site is at your own risk. Pfizer disclaims all warranties, express or implied, including warranties of merchantability of fitness for a particular purpose. Pfizer shall not be liable for any damages, including without limitation, direct, incidental, consequential, indirect or punitive damages, arising out of access to, use of, or inability to use information posted by Pfizer on the ClinicalStudyResults.org web site, or any errors or omissions in the content thereof. The ClinicalStudyResults.org web site is maintained by PhRMA, a trade association of which Pfizer is a member. PhRMA had no role in the sponsorship or conduct of the studies posted by Pfizer on ClinicalStudyResults.org.
Company Study
Protocol No. A0661149
Back to Search Results

 

 

© 2010 ClinicalStudyResults.org   |  Privacy Policy  |  Contact Us